Indomethacin therapy and fetal urine production in twins with polyhydramnios
- 1 January 1991
- journal article
- research article
- Published by Walter de Gruyter GmbH in jpme
- Vol. 19 (3) , 173-176
- https://doi.org/10.1515/jpme.1991.19.3.173
Abstract
Indomethacin has been used in twins with polyhydramnios to decrease amniotic fluid volume. Under therapy, a marked reduction of both fetuses' urine production has been demonstrated within 24 hours concomitant with maternal symptomatic relief. Discontinuation of therapy was associated with a rapid increase in fetal urine production. The clinical observation indicates that the benefit of indomethacin in prolonging such pregnancies is most probably the result of relief of polyhydramnios through decreased fetal urine production.Keywords
This publication has 11 references indexed in Scilit:
- Indomethacin-induced oligohydramniosAmerican Journal of Obstetrics and Gynecology, 1989
- Twin with hydramnios: Treating premature labor at sourceAmerican Journal of Obstetrics and Gynecology, 1989
- Indomethacin in the Treatment of Premature LaborNew England Journal of Medicine, 1988
- Polyhydramnios associated with a ring chromosome and low maternal serum α-fetoprotein levels managed with indomethacinAmerican Journal of Obstetrics and Gynecology, 1988
- PolyhydramniosObstetrical & Gynecological Survey, 1987
- Treatment of polyhydramnios with prostaglandin Synthetase inhibitor (indomethacin)American Journal of Obstetrics and Gynecology, 1987
- Further study of the inhibition of premature labor by indomethacin Part II double-blind studyjpme, 1984
- Indomethacin and renal function in premature infants with persistent patent ductus arteriosusThe Journal of Pediatrics, 1979
- Indomethacin: Studies of absorption and placental transferAmerican Journal of Obstetrics and Gynecology, 1977
- INDUCTION OF HEPATIC ENZYMES DURING NORMAL HUMAN PREGNANCYBJOG: An International Journal of Obstetrics and Gynaecology, 1973